The post Injective (INJ) Price Jumps 5% on Staked ETF Filing News appeared on BitcoinEthereumNews.com.

Canary Capital has filed a trust in Delaware for an INJ staking ETF. The move seeks to offer staking exposure to the Injective token. The news sparks a 3.7% gain in INJ over the last 24 hours. Asset management firm Canary Capital has filed for a trust in Delaware to create a product offering staking exposure to the Injective (INJ) token, a move that pushes the boundaries of crypto-based financial products in the United States.  The development, which has fueled a rally in the INJ token, comes as U.S. regulators are signaling concerns over the legality of such “staked” ETF structures. Canary Capital’s Delaware Trust  The Delaware Division of Corporations website confirms that the “Canary Staked INJ ETF” was formed on Monday. This filing is typically the first step in launching an ETF in the United States.  While creating a Delaware trust does not guarantee the eventual launch of an ETF, it highlights Canary Capital’s plans to offer exposure to staked INJ. INJ Token Jumps Over 5% on ETF Filing News The news has sparked immediate interest in the INJ token. Since the announcement, the token has gained 5.41% over the past 24 hours. It now trades at $14.22, a significant improvement from the intraday low of $13.23. The ongoing bullish performance has improved INJ’s weekly trajectory. At press time, the coin boasts a seven-day return of 12%. According to DappRadar, the Injective blockchain has witnessed a slight uptick in transactions and user activity compared to figures from earlier this month. Related: Injective ($INJ) Price Prediction for May 24: Bulls Push Above Key Fib Zone as $15 Eyed Previous ETF Efforts Canary Capital has a history of exploring crypto ETFs. In April, the company filed for an ETF to hold and stake Tron (TRX) tokens, generating yield through staking. Additionally,…

---

Filed under: News - @ June 10, 2025 5:29 pm